Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1207, 2008-01, pp. : 6-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/etanercept/infliximab: Endophthalmitis leading to vision loss: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :
Access to resources
Recommend
Adalimumab/etanercept/infliximab: Demyelinating disorders: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 25 case reports
Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis: 6 case reports
Reactions Weekly, Vol. 1, Iss. 1438, 2013-01 ,pp. :